Open Label, Randomized, Parallel-Group, Multi-Centre Study to Evaluate the Safety, Tolerability and Immunogenicity of an AS03B /oil-in-water emulsion-adjuvanted (AS03B) split-virion vs. non-adjuvanted whole virion H1N1 influenza vaccine in UK children 6 months to 12 years of age

CS Waddington; WT Walker; C Oeser; A Reiner; T John; S Wilkins; M Casey; PE Eccleston; RJ Allen; I Okike; S Ladhani; E Sheasby; K Hoschler; N Andrews; P Waight; AC Collinson; PT Heath; A Finn; SN Faust; MD Snape; E Miller; Andrew Pollard

doi:10.3310/hta14460-01

Open Label, Randomized, Parallel-Group, Multi-Centre Study to Evaluate the Safety, Tolerability and Immunogenicity of an AS03B /oil-in-water emulsion-adjuvanted (AS03B) split-virion vs. non-adjuvanted whole virion H1N1 influenza vaccine in UK children 6 months to 12 years of age

CS Waddington, WT Walker, C Oeser, A Reiner, T John, S Wilkins, M Casey, PE Eccleston, RJ Allen, I Okike, S Ladhani, E Sheasby, K Hoschler, N Andrews, P Waight, AC Collinson, PT Heath, A Finn, SN Faust, MD SnapeE Miller, Andrew Pollard

Research output: Contribution to journal › Article (Academic Journal) › peer-review

17 Citations (Scopus)

Abstract

Open Label, Randomized, Parallel-Group, Multi-Centre Study to Evaluate the Safety, Tolerability and Immunogenicity of an AS03B /oil-in-water emulsion-adjuvanted (AS03B) split-virion vs. non-adjuvanted whole virion H1N1 influenza vaccine in UK children 6 months to 12 years of age

Translated title of the contribution	Open Label, Randomized, Parallel-Group, Multi-Centre Study to Evaluate the Safety, and Immunogenicity of an AS03B /oil-in-water emulsion-adjuvanted split-virion vs. non-adjuvanted whole virion H1N1 influenza vaccine in UK children 6 months to 12 years of age
Original language	English
Article number	1
Number of pages	131
Journal	Health Technology Assessment
Volume	14
Issue number	46
DOIs	https://doi.org/10.3310/hta14460-01
Publication status	Published - Oct 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.3310/hta14460-01

Handle.net

Persistent link

Fingerprint

Dive into the research topics of 'Open Label, Randomized, Parallel-Group, Multi-Centre Study to Evaluate the Safety, Tolerability and Immunogenicity of an AS03B /oil-in-water emulsion-adjuvanted (AS03B) split-virion vs. non-adjuvanted whole virion H1N1 influenza vaccine in UK children 6 months to 12 years of age'. Together they form a unique fingerprint.

Cite this

Waddington, CS., Walker, WT., Oeser, C., Reiner, A., John, T., Wilkins, S., Casey, M., Eccleston, PE., Allen, RJ., Okike, I., Ladhani, S., Sheasby, E., Hoschler, K., Andrews, N., Waight, P., Collinson, AC., Heath, PT., Finn, A., Faust, SN., ... Pollard, A. (2010). Open Label, Randomized, Parallel-Group, Multi-Centre Study to Evaluate the Safety, Tolerability and Immunogenicity of an AS03B /oil-in-water emulsion-adjuvanted (AS03B) split-virion vs. non-adjuvanted whole virion H1N1 influenza vaccine in UK children 6 months to 12 years of age. Health Technology Assessment, 14(46), Article 1. https://doi.org/10.3310/hta14460-01

Waddington, CS ; Walker, WT ; Oeser, C et al. / Open Label, Randomized, Parallel-Group, Multi-Centre Study to Evaluate the Safety, Tolerability and Immunogenicity of an AS03B /oil-in-water emulsion-adjuvanted (AS03B) split-virion vs. non-adjuvanted whole virion H1N1 influenza vaccine in UK children 6 months to 12 years of age. In: Health Technology Assessment. 2010 ; Vol. 14, No. 46.

@article{cc3ab5a2803d43c7b6c60901c399e1a7,

title = "Open Label, Randomized, Parallel-Group, Multi-Centre Study to Evaluate the Safety, Tolerability and Immunogenicity of an AS03B /oil-in-water emulsion-adjuvanted (AS03B) split-virion vs. non-adjuvanted whole virion H1N1 influenza vaccine in UK children 6 months to 12 years of age",

abstract = "Open Label, Randomized, Parallel-Group, Multi-Centre Study to Evaluate the Safety, Tolerability and Immunogenicity of an AS03B /oil-in-water emulsion-adjuvanted (AS03B) split-virion vs. non-adjuvanted whole virion H1N1 influenza vaccine in UK children 6 months to 12 years of age",

author = "CS Waddington and WT Walker and C Oeser and A Reiner and T John and S Wilkins and M Casey and PE Eccleston and RJ Allen and I Okike and S Ladhani and E Sheasby and K Hoschler and N Andrews and P Waight and AC Collinson and PT Heath and A Finn and SN Faust and MD Snape and E Miller and Andrew Pollard",

year = "2010",

month = oct,

doi = "10.3310/hta14460-01",

language = "English",

volume = "14",

journal = "Health Technology Assessment",

issn = "1366-5278",

publisher = "NIHR Journals Library",

number = "46",

}

Waddington, CS, Walker, WT, Oeser, C, Reiner, A, John, T, Wilkins, S, Casey, M, Eccleston, PE, Allen, RJ, Okike, I, Ladhani, S, Sheasby, E, Hoschler, K, Andrews, N, Waight, P, Collinson, AC, Heath, PT, Finn, A, Faust, SN, Snape, MD, Miller, E & Pollard, A 2010, 'Open Label, Randomized, Parallel-Group, Multi-Centre Study to Evaluate the Safety, Tolerability and Immunogenicity of an AS03B /oil-in-water emulsion-adjuvanted (AS03B) split-virion vs. non-adjuvanted whole virion H1N1 influenza vaccine in UK children 6 months to 12 years of age', Health Technology Assessment, vol. 14, no. 46, 1. https://doi.org/10.3310/hta14460-01

Open Label, Randomized, Parallel-Group, Multi-Centre Study to Evaluate the Safety, Tolerability and Immunogenicity of an AS03B /oil-in-water emulsion-adjuvanted (AS03B) split-virion vs. non-adjuvanted whole virion H1N1 influenza vaccine in UK children 6 months to 12 years of age. / Waddington, CS; Walker, WT; Oeser, C et al.
In: Health Technology Assessment, Vol. 14, No. 46, 1, 10.2010.

Research output: Contribution to journal › Article (Academic Journal) › peer-review

TY - JOUR

T1 - Open Label, Randomized, Parallel-Group, Multi-Centre Study to Evaluate the Safety, Tolerability and Immunogenicity of an AS03B /oil-in-water emulsion-adjuvanted (AS03B) split-virion vs. non-adjuvanted whole virion H1N1 influenza vaccine in UK children 6 months to 12 years of age

AU - Waddington, CS

AU - Walker, WT

AU - Oeser, C

AU - Reiner, A

AU - John, T

AU - Wilkins, S

AU - Casey, M

AU - Eccleston, PE

AU - Allen, RJ

AU - Okike, I

AU - Ladhani, S

AU - Sheasby, E

AU - Hoschler, K

AU - Andrews, N

AU - Waight, P

AU - Collinson, AC

AU - Heath, PT

AU - Finn, A

AU - Faust, SN

AU - Snape, MD

AU - Miller, E

AU - Pollard, Andrew

PY - 2010/10

Y1 - 2010/10

N2 - Open Label, Randomized, Parallel-Group, Multi-Centre Study to Evaluate the Safety, Tolerability and Immunogenicity of an AS03B /oil-in-water emulsion-adjuvanted (AS03B) split-virion vs. non-adjuvanted whole virion H1N1 influenza vaccine in UK children 6 months to 12 years of age

AB - Open Label, Randomized, Parallel-Group, Multi-Centre Study to Evaluate the Safety, Tolerability and Immunogenicity of an AS03B /oil-in-water emulsion-adjuvanted (AS03B) split-virion vs. non-adjuvanted whole virion H1N1 influenza vaccine in UK children 6 months to 12 years of age

U2 - 10.3310/hta14460-01

DO - 10.3310/hta14460-01

M3 - Article (Academic Journal)

C2 - 20923610

SN - 1366-5278

VL - 14

JO - Health Technology Assessment

JF - Health Technology Assessment

IS - 46

M1 - 1

ER -

Waddington CS, Walker WT, Oeser C, Reiner A, John T, Wilkins S et al. Open Label, Randomized, Parallel-Group, Multi-Centre Study to Evaluate the Safety, Tolerability and Immunogenicity of an AS03B /oil-in-water emulsion-adjuvanted (AS03B) split-virion vs. non-adjuvanted whole virion H1N1 influenza vaccine in UK children 6 months to 12 years of age. Health Technology Assessment. 2010 Oct;14(46):1. doi: 10.3310/hta14460-01